A Phase 2, Multicenter, Randomized, Double Blind, Dose Escalating/ De-Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sustained Release Encapsulated Bupivacaine (SKY0402) Administered as a Nerve Block in the Management of Postoperative Pain in Subjects Undergoing Bunionectomy.
Phase of Trial: Phase II
Latest Information Update: 14 May 2012
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain; Regional anaesthesia
- Focus Therapeutic Use
- 29 Sep 2010 New trial record